Module contents

Module home

Module introduction
Module information

Related articles: BJPsych Advances
About the authors

Learning notes

Pre-module test

 

Section 1: Treatment options in opioid dependence

(1.1) Section 1: Treatment options in opioid dependence

(1.2) The size of the problem: UK

(1.3) The size of the problem: Scotland

(1.4) Interactive exercise: probability of infection

(1.5) Reflection

(1.6) The role of prescribing in opioid dependence

(1.7) NICE-approved interventions

(1.8) Interactive exercise: choice of treatment modality

(1.9) Section 1: Recap

(1.10) Section 1: Summary

 

Section 2: Understanding how buprenorphine works

(2.1) Section 2: Understanding how buprenorphine works

(2.2) Buprenorphine as a mixed agonist-antagonist opioid

(2.3) The pharmacology of buprenorphine – partial agonist at μ receptor

(2.4) Effect of illicit opioid use when taking buprenorphine

(2.5) How buprenorphine works

(2.6) Pharmacology of buprenorphine – other properties

(2.7) Dosing of buprenorphine

(2.8) Buprenorphine and naloxone preparations

(2.9) Advantages and disadvantages of buprenorphine treatment

(2.10) Pregnancy: a special case?

(2.11) Management of buprenorphine in pregnancy

(2.12) Reflection

(2.13) Reflection: pointers

(2.14) Section 2: Recap

(2.15) Section 2: Summary

 

Section 3: Buprenorphine prescribing, induction and titration

(3.1) Section 3: Buprenorphine prescribing, induction and titration

(3.2) Assessment

(3.3) Which opioid-dependent patients are likely to do well on buprenorphine?

(3.4) Which opioid-dependent patients are likely to do well on buprenorphine?

(3.5) Clinical vignette: Dave

(3.6) Reflection: suggested answers

(3.7) Getting someone started on buprenorphine

(3.8) Getting someone started on buprenorphine

(3.9) Giving the initial dose

(3.10) Inadequate dose or precipitated withdrawals

(3.11) Precipitated withdrawal

(3.12) Inadequate dose of buprenorphine

(3.13) Clinical vignette: Steven

(3.14) Suggested answers

(3.15) Section 3: Recap

(3.16) Section 3: Summary

 

Section 4: Maintaining treatment on buprenorphine

(4.1) Section 4: Maintaining treatment on buprenorphine

(4.2) Titration to optimal dose

(4.3) Maintaining a patient on buprenorphine

(4.4) Clinical vignette: Danielle

(4.5) Suggested answers

(4.6) Section 4: Recap

(4.7) Section 4: Summary

 

Section 5: Detoxification from opioids using buprenorphine

(5.1) Section 5: Detoxification from opioids using buprenorphine

(5.2) When to start a detoxification programme

(5.3) Interactive exercise: how to reduce and stop buprenorphine

(5.4) Example 1: brief buprenorphine detoxification regimen

(5.5) Example 2: standard 28-day buprenorphine detoxification regimen

(5.6) Relapse prevention

(5.7) Reviewing the patient's progress through treatment

(5.8) Section 5: Recap

(5.9) Section 5: Summary

 

Module summary

Module test

Acknowledgements

Send feedback

 

Useful resources

Take-home notes

References

Further reading

© 2020 Royal College of Psychiatrists